BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 18330650)

  • 21. [Surgical axilla dissection. Technical standard or obsolete method?].
    Bachleitner-Hofmann T; Gnant M
    Zentralbl Chir; 2000; 125(10):822-9. PubMed ID: 11098577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches in breast cancer management: sentinel node biopsy and intraoperative radiotherapy.
    Keshtgar MR; Chicken DW; Tobias JS
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):218-26. PubMed ID: 16468472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancer.
    Tanguay JS; Ford DR; Sadler G; Buckley L; Uppal H; Cross J; Holmes N; Fortes Mayer K; Fernando I
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):677-82. PubMed ID: 18722758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of axillary and internal mammary lymph nodes in primary breast cancer].
    Masuda N; Tamaki Y; Noguchi S
    Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):465-72. PubMed ID: 11436509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH; Fey JV; Borgen PI; Stempel MM; Hardick KR; Van Zee KJ
    Ann Surg Oncol; 2007 May; 14(5):1653-61. PubMed ID: 17295084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary management after sentinel lymph node biopsy in breast cancer patients.
    Rivers A; Hansen N
    Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer.
    Trocha SD; Giuliano AE
    Surg Oncol; 2003 Dec; 12(4):271-6. PubMed ID: 14998567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
    Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
    Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH; Fey JV; Borgen PI; Van Zee KJ
    Oncol Nurs Forum; 2004 Jul; 31(4):691-8. PubMed ID: 15252425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
    Wang Z; Wu LC; Chen JQ
    Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of axillary staging in early breast cancer: a meta-analysis.
    Kell MR; Burke JP; Barry M; Morrow M
    Breast Cancer Res Treat; 2010 Apr; 120(2):441-447. PubMed ID: 20063121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.
    Menard JP; Extra JM; Jacquemier J; Buttarelli M; Lambaudie E; Bannier M; Brenot Rossi I; Houvenaeghel G
    Eur J Surg Oncol; 2009 Sep; 35(9):916-20. PubMed ID: 19157769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.